⌘K

Home/Filings/4/0001209191-22-062586

4//SEC Filing

Ji Henry 4

Accession 0001209191-22-062586

CIK 0000850261other

View on SEC.gov Company Profile

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 2:28 PM ET

Size

13.1 KB

Accession

0001209191-22-062586

Insider Transaction Report

Form 4

Period: 2022-12-02

Sorrento Therapeutics, Inc.SRNE

DirectorChief Sci. Officer & Secretary10% Owner

Transactions

Exercise of In-Money
Put Option (obligation to buy)
2022-12-21−3→ 195 total(indirect: By BioVintage, Inc.)
Exercise: $5.50From: 2022-08-26Exp: 2023-03-17→ Common Stock (300 underlying)
Exercise of In-Money
Common Stock
2022-12-02$5.50/sh+200$1,100→ 200 total(indirect: By BioVintage, Inc.)
Exercise of In-Money
Common Stock
2022-12-21$5.50/sh+300$1,650→ 500 total(indirect: By BioVintage, Inc.)
Exercise of In-Money
Put Option (obligation to buy)
2022-12-02−2→ 198 total(indirect: By BioVintage, Inc.)
Exercise: $5.50From: 2022-08-26Exp: 2023-03-17→ Common Stock (200 underlying)

Holdings

Common Stock
6,265,805
Common Stock
(indirect: See Footnote)
2,271,693
Common Stock
(indirect: By Spouse)
40,000

Footnotes (1)

[F1]Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Sorrento Therapeutics, Inc.

CIK 0000850261

Entity typeother

Related Parties

1

filerCIK 0001470981

Filing Metadata

Form type: 4
Filed: Dec 22, 7:00 PM ET
Accepted: Dec 23, 2:28 PM ET
Size: 13.1 KB

View on SEC.gov